Filing Details

Accession Number:
0001144204-15-070766
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-14 17:05:18
Reporting Period:
2015-12-10
Filing Date:
2015-12-14
Accepted Time:
2015-12-14 17:05:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1137883 Brainstorm Cell Therapeutics Inc. BCLI Biological Products, (No Disgnostic Substances) (2836) 207273918
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1305117 S Malcolm Taub 605 Third Avenue
34Th Floor
New York NY 10158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-12-10 12,500 $2.74 51,388 No 4 S Direct
Common Stock Disposition 2015-12-11 980 $2.66 50,408 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.